Evaluation of a temporary vaccination recommendation in response to an outbreak of invasive meningococcal serogroup C disease in men who have sex with men in Berlin, 2013-2014

Euro Surveill. 2016;21(5):12-22. doi: 10.2807/1560-7917.ES.2016.21.5.30122.

Abstract

Meningococcal serogroup C (MenC) vaccination of men who have sex with men (MSM) was temporarily recommended to control an outbreak of invasive MenC disease among MSM in Berlin in 2012-2013. Vaccination was offered to HIV-infected MSM free of charge; others had to request reimbursement or pay out of pocket. We aimed to assess (i) awareness and acceptance of this recommendation through an online survey of MSM, (ii) implementation through a survey of primary care physicians and analysis of vaccine prescriptions, and (iii) impact through analysis of notified cases. Among online survey respondents, 60% were aware of the recommendation. Of these, 39% had obtained vaccination (70% of HIV-infected, 13% of HIV-negative/non-tested MSM). Awareness of recommendation and vaccination were positively associated with HIV infection, primary care physicians' awareness of respondents' sexual orientation, and exposure to multiple information sources. Most (26/30) physicians informed clients about the recommendation. Physicians considered concerns regarding reimbursement, vaccine safety and lack of perceived disease risk as primary barriers. After the recommendation, no further outbreak-related cases occurred. To reach and motivate target groups, communication of a new outbreak-related vaccination recommendation should address potential concerns through as many information channels as possible and direct reimbursement of costs should be enabled.

Keywords: Neisseria meningitidis (Nm); evaluation; men who have sex with men (MSM); outbreak control; survey; vaccine recommendation.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Berlin / epidemiology
  • Disease Outbreaks*
  • Germany
  • Health Care Surveys
  • Homosexuality, Male / statistics & numerical data*
  • Humans
  • Male
  • Meningococcal Infections / epidemiology*
  • Meningococcal Vaccines / administration & dosage*
  • Middle Aged
  • Nasopharynx / microbiology
  • Neisseria meningitidis, Serogroup C / immunology
  • Neisseria meningitidis, Serogroup C / isolation & purification*
  • Patient Acceptance of Health Care / statistics & numerical data*
  • Prevalence
  • Program Evaluation
  • Sexual Partners
  • Vaccination / statistics & numerical data*
  • Young Adult

Substances

  • Meningococcal Vaccines